Expression of novel immunotherapeutic targets in triple-negative breast cancer


Gargi D. Basu PhD, Anatole Ghazalpour PhD, Zoran Gatalica MD, Karen S. Anderson MD, Ann McCullough MD, David Spetzler PhD, Barbara A. Pockaj MD

Learning Objectives

  • Discuss immune checkpoints and their ramifications in human cancers
  • Evaluate the presence of PD-L1 expression in a large breast cancer population
  • Identify immune and molecular pathway associations with PD-L1
  • Review preliminary validation data

Download Publication